Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
2076
DELISTED
Accelerate Diagnostics
AXDX
| $1.04M | ﹤0.01% |
6,860
+1,030
| +18% | +$156K |
|
2077
UroGen Pharma
URGN
$869M
| $1.04M | ﹤0.01% |
39,800
+5,300
| +15% | +$138K |
|
2078
Origin Bancorp
OBK
$1.11B
| $1.04M | ﹤0.01% |
47,182
+13,000
| +38% | +$286K |
|
2079
Buckle
BKE
$3.04B
| $1.03M | ﹤0.01% |
65,900
+8,600
| +15% | +$135K |
|
|
BEST
2080
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $1.03M | ﹤0.01% |
+12,050
| New | +$1.03M |
|
2081
Central Pacific Financial
CPF
$826M
| $1.03M | ﹤0.01% |
64,200
+9,500
| +17% | +$152K |
|
2082
The RMR Group
RMR
$288M
| $1.03M | ﹤0.01% |
34,892
+5,200
| +18% | +$153K |
|
2083
Quanex
NX
$661M
| $1.03M | ﹤0.01% |
73,900
+9,600
| +15% | +$133K |
|
2084
Great Southern Bancorp
GSBC
$710M
| $1.03M | ﹤0.01% |
25,400
+3,300
| +15% | +$133K |
|
|
EIDX
2085
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.03M | ﹤0.01% |
21,500
+7,000
| +48% | +$334K |
|
|
CFB
2086
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.02M | ﹤0.01% |
+104,700
| New | +$1.02M |
|
|
MNRL
2087
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $1.02M | ﹤0.01% |
82,700
+25,900
| +46% | +$320K |
|
2088
Owens & Minor
OMI
$412M
| $1.02M | ﹤0.01% |
133,700
+13,200
| +11% | +$101K |
|
2089
American Public Education
APEI
$645M
| $1.02M | ﹤0.01% |
34,400
+3,900
| +13% | +$115K |
|
|
FBMS
2090
DELISTED
The First Bancshares, Inc.
FBMS
| $1.02M | ﹤0.01% |
45,230
+10,600
| +31% | +$239K |
|
|
RESI
2091
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.02M | ﹤0.01% |
116,900
+17,600
| +18% | +$153K |
|
2092
Impinj
PI
$5.2B
| $1.02M | ﹤0.01% |
37,000
+4,800
| +15% | +$132K |
|
|
DRRX
2093
DELISTED
DURECT Corp
DRRX
| $1.01M | ﹤0.01% |
+43,710
| New | +$1.01M |
|
2094
Catalyst Pharmaceutical
CPRX
$2.44B
| $1.01M | ﹤0.01% |
219,300
+39,400
| +22% | +$182K |
|
2095
Zynex
ZYXI
$44.8M
| $1.01M | ﹤0.01% |
+44,770
| New | +$1.01M |
|
|
SP
2096
DELISTED
SP Plus Corporation
SP
| $1.01M | ﹤0.01% |
48,800
+4,300
| +10% | +$89.1K |
|
2097
Pitney Bowes
PBI
$1.96B
| $1M | ﹤0.01% |
386,200
+54,800
| +17% | +$142K |
|
|
SDC
2098
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $1M | ﹤0.01% |
+127,100
| New | +$1M |
|
2099
HarborOne Bancorp
HONE
$563M
| $1M | ﹤0.01% |
117,384
+67,100
| +133% | +$573K |
|
2100
LeMaitre Vascular
LMAT
$2.09B
| $1M | ﹤0.01% |
37,900
+4,900
| +15% | +$129K |
|